October 2026
Ribavirin hantavirus outcomes
StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Huggins (DB RCT)74%0.26 · 0.07–0.93death3/12210/107HFRS, Hantaan
Huggins (DB RCT)74%0.26 · 0.07–0.93death3/12210/107HFRS, Hantaan
Huggins (DB RCT)84%0.16 · 0.03–0.85death3/12210/107HFRS, Hantaan
Huggins (DB RCT)73%0.27 · 0.10–0.73progression122 (n)107 (n)HFRS, Hantaan
Malinin (RCT)67%0.33 · 0.01–7.85progression0/371/36HFRS, Puumala
Malinin (RCT)−17%1.17 · 1.01–1.36progression37 (n)36 (n)HFRS, Puumala
Malinin (RCT)−15%1.15 · 0.97–1.38viral time37 (n)36 (n)HFRS, Puumala
Mertz (DB RCT)−30%1.30 · 0.22–7.69death2/102/13HCPS, Sin Nombre
Mertz (DB RCT)22%0.78 · 0.24–2.51progression3/105/13HCPS, Sin Nombre
00.511.52+